Pregled bibliografske jedinice broj: 153200
Analysis of NF1 gene in sporadic colon cancer
Analysis of NF1 gene in sporadic colon cancer // Abstracts of the European Human Genetics Conference 2004 in European Journal of Human Genetics / European Society of Human Genetics (ur.).
München: Nature publishing group, 2004. str. 168-168 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 153200 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Analysis of NF1 gene in sporadic colon cancer
Autori
Čačev, Tamara ; Radošević, Senka ; Spaventi, Radan ; Pavelić, Krešimir ; Kapitanović, Sanja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the European Human Genetics Conference 2004 in European Journal of Human Genetics
/ European Society of Human Genetics - München : Nature publishing group, 2004, 168-168
Skup
European Human Genetics Conference 2004
Mjesto i datum
München, Njemačka, 12.06.2004. - 15.06.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
NF1 gene expression; sporadic colon cancer
Sažetak
Tumorigenesis of colon cancer is a multistep process of mutation accumulation in a number of oncogenes and tumor suppressor genes. NF1 protein product, neurofibromin, acts as a tumor suppressor by turning the active form of Ras into an inactive one. This molecular switch has an important role in the control of cell cycle and differentiation and the changes in the Ras activity are involved in number cancers. Several different isoforms are formed by alternative splicing of NF1 mRNA. Isoform type I was the first isolated isoform that lacks any insertions. Isoform type II contains an additional 63 bp insertion (exon 23a). These two isoforms are expressed at varying ratios in different cell types Several studies have shown that alterations in the type I vs. type II mRNA ratio can be associated with the development of certain malignancies. In this study we investigated the loss of heterozygosity (LOH) of the NF1 gene in 100 sporadic colon cancers. Quantitative RT-PCR was used to determine the NF1 mRNA expression in tumor and corresponding normal mucous tissue. Relative ratio of NF1 types I and II expression was examined as well. The results were correlated with the patients' clinicopathological features. LOH was observed in 20.7 % of informative samples. Expression of NF1 mRNA was higher in well differentiated tumors and tumors classified as Dukes' A. NF1 isoform type II was dominantly expressed in normal mucous tissue, while the isoform type I was dominantly expressed in tumor tissue.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Krešimir Pavelić
(autor)
Sanja Kapitanović
(autor)
Senka Radošević
(autor)
Radan Spaventi
(autor)
Tamara Čačev
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE